Efficacy and Safety of GLP-1 Receptor Agonists in Patients With Type 2 Diabetes Mellitus and Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis

The prevalence of non-alcoholic fatty liver disease (NAFLD) in patients with type 2 diabetes mellitus (T2DM) is increasing and there is an urgent need for new treatment strategy to prevent progression of hepatic steatosis and fibrosis. We have performed a systematic review and meta-analysis of rando...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Yuan, Xu, Jiao, Zhang, Dong, Mu, Xingyu, Shi, Yi, Chen, Shangtao, Wu, Zengxiang, Li, Shuangqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8696030/
https://www.ncbi.nlm.nih.gov/pubmed/34956080
http://dx.doi.org/10.3389/fendo.2021.769069

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8696030/
https://www.ncbi.nlm.nih.gov/pubmed/34956080
http://dx.doi.org/10.3389/fendo.2021.769069

Ejemplares similares